|
Volumn 122, Issue 5, 2013, Pages 1122-1131
|
Hypertension in pregnancy: Executive summary
a a a a a a a a a a a a a a a a a a a a more..
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
CALCIUM;
CORTICOSTEROID;
MAGNESIUM SULFATE;
MINERALOCORTICOID ANTAGONIST;
ADVERSE OUTCOME;
ANTIHYPERTENSIVE THERAPY;
ARTICLE;
BED REST;
CESAREAN SECTION;
CLINICAL PRACTICE;
DISEASE CLASSIFICATION;
ECLAMPSIA;
ELEVATED BLOOD PRESSURE;
EVIDENCE BASED PRACTICE;
FETAL WELL BEING;
FETUS GROWTH;
FETUS LUNG MATURITY;
FETUS MONITORING;
FETUS OUTCOME;
HELLP SYNDROME;
HUMAN;
KIDNEY FAILURE;
LOW DRUG DOSE;
MATERNAL HYPERTENSION;
MATERNAL MORBIDITY;
MATERNAL MORTALITY;
PREDICTION;
PREECLAMPSIA;
PREGNANCY;
PREGNANCY OUTCOME;
PRIORITY JOURNAL;
PROTEINURIA;
PUERPERIUM;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SODIUM RESTRICTION;
THROMBOCYTE COUNT;
THROMBOCYTOPENIA;
|
EID: 84887183180
PISSN: 00297844
EISSN: 1873233X
Source Type: Journal
DOI: 10.1097/01.AOG.0000437382.03963.88 Document Type: Article |
Times cited : (982)
|
References (0)
|